Alcon AG | Kostnadene For Salg



Cost Of Sales Endring Dato
AstraZeneca USD 2.72B 263M 2024-12
Bayer EUR 5.72B 633M 2024-12
Essilor EUR 2.53B 83M 2024-12
Fresenius EUR 4.22B 212M 2024-12
Fresenius Medical Care EUR 3.81B 200M 2024-12
GlaxoSmithKline GBP 2.56B 162M 2024-12
GRIFOLS EUR 1.21B 143.12M 2024-12
Lonza CHF 1.94B 858M 2024-06
Merck EUR 2.32B 197M 2024-12
Novartis USD 3.32B 90M 2024-12
Philips EUR 3.08B 710M 2024-12
Roche Holding CHF 4.13B 393.5M 2024-12
Sanofi EUR 4.08B 675M 2024-09
Smith & Nephew USD 911M 58M 2024-12
Sonova Holding CHF 514.8M 7M 2024-09
UCB EUR 425.5M 479.5M 2024-06



Alcon AG Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.